En el IBEC estamos trabajando para descifrar cómo se desarrolla la Covid-19, para poder evitar su avance, encontrar tratamientos más eficaces y mitigar las secuelas de quienes ya la han padecido o la van a padecer.
Nuestro propósito es acelerar esta investigación, por eso esta vez te vamos a pedir algo inusual: "NO TE LAVES LAS MANOS", necesitamos que te impliques.
A new study by IBEC’s Bacterial Infections: Antimicrobial Therapies and Molecular and cellular neurobiotechnology groups shows that Galleria mellonella larvae can be effective to test the toxicity of nanoparticles. This work thus paves the way toward a new animal model for toxicity studies that represent an inexpensive and more ethical alternative to rodent testing.
An international team led by the SPECS Laboratory at the IBEC has identified, for the first time in humans, the physiological mechanism responsible for the effectiveness of learning processes based on self-motivation and freedom of choice. The protagonists of this mechanism are theta-type brain waves, which regulate the ability of the human hippocampus to fix and retrieve information.
The Spanish Nanomedicine Platform (Nanomed Spain) has renewed the “Aid to Technological and Innovation Platforms” for the period 2021-2022 granted by the Ministry of Science and Innovation. Josep Samitier, director of the Institute for Bioengineering of Catalonia, coordinates the Nanomed Spain platform since its foundation in 2005.
The “la Caixa” Foundation and BIST are creating a chemical biology programme to promote two new cutting-edge research groups at IBEC and IRB (both centres are members of BIST). The initiative aims to attract talent from the field of chemical biology, and to create an ecosystem that fosters research excellence in improving health.